9 Result(s)

Article

Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma

The epidermal growth factor (EGF)/EGF-receptor (ErbB1-4) family is involved in the biology of multiple myeloma (MM). In particular, ErbB-specific inhibitors induce strong apoptosis of myeloma cells (MMC) in vitro

K Mahtouk, F W Cremer, T Rème, M Jourdan, M Baudard, J Moreaux, G Requirand… in Oncogene (2006)

Article

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation

In multiple myeloma (MM), circulating malignant B cells are proposed as the proliferative compartment of the disease. In view of the close relationship between multiple myeloma and primary plasma cell leukemi...

C. Gemmel, F. Cremer, M. Weis, M. Witzens, G. Moldenhauer… in Annals of Hematology (2002)

Article

CD19⁺ and CD20⁺ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8

T Bösing, F Bellos, FW Cremer, C Gemmel, G Moldenhauer, AD Ho, H Goldschmidt… in Leukemia (2000)

Article

The remission status before and the PCR status after high-dose therapy with peripheral blood stem cell support are prognostic factors for relapse-free survival in patients with follicular non-Hodgkin’s lymphoma

It was the aim of our study to examine the clinical significance of t(14;18)-positive cells in samples from 47 patients with follicular non-Hodgkin’s lymphoma (NHL) who underwent high-dose therapy with autolog...

M Moos, R Schulz, S Martin, A Benner, R Haas in Leukemia (1998)

Chapter and Conference Paper

Myeloablative Hochdosistherapie mit Blutstammzellentransplantation bei Patienten mit zentroblastisch-zentrozytischem Non-Hodgkin-Lymphom

Zentroblastisch-zentrozytische (CB-CC-)Non-Hodgkin-Lymphome (NHL) werden nach der Kiel-Klassifikation [9] aufgrund pathomorphologischer Kriterien und ihres klinischen Verlaufes als niedrigmaligne eingestuft [1...

R. Haas, S. Murea, S. Hohaus, M. Moos, H. Goldschmidt, M. Wannenmacher… in Maligne Lymphome (1997)

Chapter and Conference Paper

Fluorescence In Situ Hybridization for the Diagnosis and Follow-up of BCR-ABL Positive ALL

The BCR-ABL fusion, which is the molecular counterpart of the t(9;22), is the most common genetic abnormality in adult acute lymphoblastic leukemia (ALL) [1]. Due to its important diagnostic and prognostic sig...

G. P. Cabot, M. Bentz, K. Fischer, A. Ganser, M. Moos, C. Scholl… in Acute Leukemias V (1996)

Chapter and Conference Paper

Designing Probe Sets for the Detection of Chromosome Abnormalities in Acute Myeloid Leukemia Using Fluorescence In Situ Hybridization

In recent years, the karyotype as a prognostic factor in acute myeloid leukemia (AML) has gained considerable interest. Clonal chromosome aberrations are identified in 50–60% of patients with AML (for review s...

K. Fischer, C. Scholl, G. Cabot, M. Moos, R. Schlenk, P. Theobald… in Acute Leukemias V (1996)

Article

Detection of minimal tumor load in blood stem cell autografts in multiple myeloma: Steady-state versus high-dose chemotherapy stem cell mobilization

H. Goldschmidt, M. Moos, F. Cremer… in Journal of Cancer Research and Clinical On… (1995)